RecruitingNot ApplicableNCT06684028
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
Sponsor
Affiliated Hospital of Jiangnan University
Enrollment
30 participants
Start Date
Jul 12, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria4
- The subjects sign the informed consent voluntarily and can complete the test according to the protocol requirements;
- Age 18-85 years old, male or female;
- Clinically diagnosed as malignant tumor, diagnostic criteria refer to biopsy or other imaging such as CT and MRI;
- ECOG score is 0-3 points;
Exclusion Criteria4
- Patients with a history or allergic constitution to any component of the developer, including alcohol;
- pregnant or lactating women;
- Patients with mental illness or related history;
- Patients who cannot or cannot undergo a PET/CT scan;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG68Ga-FAPI-JNU
Patients will receive the novel tracer 68Ga-FAPI-JNU dose of approximately 2-5 mCi per person
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06684028
Related Trials
Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
NCT0686770536 locations
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT0683556910 locations
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
NCT041414626 locations
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
NCT065603981 location
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
NCT072214091 location